A comparative study of docetaxel & B.C.G interavesical with B.C.G alone for prophylaxis of post TUR bladder cancer recurrence
Not Applicable
- Conditions
- bladder tumor.Malignant neoplasm of bladder
- Registration Number
- IRCT201101065557N1
- Lead Sponsor
- rology Reaserch Center of Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
age more than 18 years, presence of non-invasive bladder tumor (Ta,T1,CIS), grade>3, history of bladder cancer treatment, no previous radiotherapy to pelvic area, PMN>1500, HB > 8, normal LFT,
Exclusion criteria: invasive or metastatic bladder tumor, previous treatment with docetaxel, allergy to docetaxel or BCG, history of VUR or ureteral stent placement, history of malignancy over last 2 years prior to the study except for Scc skin or non-invasive tumor of cervix, immunosuppression, pregnancy or breast feeding
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hematuria. Timepoint: at presentation. Method of measurement: subjective.;Other complication. Timepoint: at presentation. Method of measurement: subjective.
- Secondary Outcome Measures
Name Time Method Recurrence of tumor. Timepoint: every 3 month. Method of measurement: cystoscopt.